Research Areas
Biography and Research Information
OverviewAI-generated summary
Tyler W. Cunningham's research focuses on critical care outcomes, particularly in pediatric populations. His work investigates acute kidney injury in newborns and adolescents undergoing complex cardiac procedures, such as the comprehensive stage II palliation and bidirectional Glenn procedure for hypoplastic left heart syndrome. Cunningham also studies the perception of cardiac disease and advanced therapies among caregivers of individuals with Duchenne muscular dystrophy, and the role of dystrophinopathy within this population. He has published work examining the effects of T helper 2 cell immunity on pre-cancerous skin lesions. Cunningham's scholarship metrics include an h-index of 3, with 17 total publications and 44 total citations. He has collaborated with researchers such as Joshua Daily and José Thomas at the University of Arkansas for Medical Sciences.
Metrics
- h-index: 3
- Publications: 18
- Citations: 45
Selected Publications
-
Is one more year – or two – worth it? A net present value analysis of career earnings for physicians pursuing academic pediatric cardiac critical care (2026)
-
Caregiver Perception of Cardiac Disease and Advanced Cardiac Therapies in Duchenne Muscular Dystrophy: A National Survey (2025)
-
Acute kidney injury in hypoplastic left heart syndrome patients following the comprehensive stage two palliation (2023)
Collaboration Network
Top Collaborators
- Acute kidney injury in hypoplastic left heart syndrome patients following the comprehensive stage two palliation
- Identifying kidney injury via urinary biomarkers after the comprehensive stage II palliation and bidirectional Glenn procedure: a pilot study
- Acute kidney injury in hypoplastic left heart syndrome patients following the comprehensive stage two palliation
- Identifying kidney injury via urinary biomarkers after the comprehensive stage II palliation and bidirectional Glenn procedure: a pilot study
- Acute kidney injury in hypoplastic left heart syndrome patients following the comprehensive stage two palliation
- Identifying kidney injury via urinary biomarkers after the comprehensive stage II palliation and bidirectional Glenn procedure: a pilot study
- Cardiac Medication Use in ACTION for Duchenne Muscular Dystrophy Cardiomyopathy
- Dystrophinopathy in ACTION: The first 500 males enrolled in the Advanced Cardiac Therapies Improving Outcomes Network prospective dystrophinopathy registry
- Cardiac Medication Use in ACTION for Duchenne Muscular Dystrophy Cardiomyopathy
- Dystrophinopathy in ACTION: The first 500 males enrolled in the Advanced Cardiac Therapies Improving Outcomes Network prospective dystrophinopathy registry
- Cardiac Medication Use in ACTION for Duchenne Muscular Dystrophy Cardiomyopathy
- Dystrophinopathy in ACTION: The first 500 males enrolled in the Advanced Cardiac Therapies Improving Outcomes Network prospective dystrophinopathy registry
- Cardiac Medication Use in ACTION for Duchenne Muscular Dystrophy Cardiomyopathy
- Dystrophinopathy in ACTION: The first 500 males enrolled in the Advanced Cardiac Therapies Improving Outcomes Network prospective dystrophinopathy registry
- Cardiac Medication Use in ACTION for Duchenne Muscular Dystrophy Cardiomyopathy
- Dystrophinopathy in ACTION: The first 500 males enrolled in the Advanced Cardiac Therapies Improving Outcomes Network prospective dystrophinopathy registry
- Cardiac Medication Use in ACTION for Duchenne Muscular Dystrophy Cardiomyopathy
- Dystrophinopathy in ACTION: The first 500 males enrolled in the Advanced Cardiac Therapies Improving Outcomes Network prospective dystrophinopathy registry
- Cardiac Medication Use in ACTION for Duchenne Muscular Dystrophy Cardiomyopathy
- Dystrophinopathy in ACTION: The first 500 males enrolled in the Advanced Cardiac Therapies Improving Outcomes Network prospective dystrophinopathy registry
- Cardiac Medication Use in ACTION for Duchenne Muscular Dystrophy Cardiomyopathy
- Dystrophinopathy in ACTION: The first 500 males enrolled in the Advanced Cardiac Therapies Improving Outcomes Network prospective dystrophinopathy registry
- Cardiac Medication Use in ACTION for Duchenne Muscular Dystrophy Cardiomyopathy
- Dystrophinopathy in ACTION: The first 500 males enrolled in the Advanced Cardiac Therapies Improving Outcomes Network prospective dystrophinopathy registry
- Cardiac Medication Use in ACTION for Duchenne Muscular Dystrophy Cardiomyopathy
- Dystrophinopathy in ACTION: The first 500 males enrolled in the Advanced Cardiac Therapies Improving Outcomes Network prospective dystrophinopathy registry
- Cardiac Medication Use in ACTION for Duchenne Muscular Dystrophy Cardiomyopathy
- Dystrophinopathy in ACTION: The first 500 males enrolled in the Advanced Cardiac Therapies Improving Outcomes Network prospective dystrophinopathy registry
- Cardiac Medication Use in ACTION for Duchenne Muscular Dystrophy Cardiomyopathy
- Dystrophinopathy in ACTION: The first 500 males enrolled in the Advanced Cardiac Therapies Improving Outcomes Network prospective dystrophinopathy registry
Similar Researchers
Based on overlapping research topics